2012 -- H 7574

=======

LC01487

=======

STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2012

____________

A N A C T

RELATING TO FOOD AND DRUGS -- DRUG ABUSE AND OVERDOSE PREVENTION

ACT

     Introduced By: Representatives Ferri, Palumbo, Edwards, Marcello, and Bennett

     Date Introduced: February 15, 2012

     Referred To: House Health, Education & Welfare

It is enacted by the General Assembly as follows:

1-1

     SECTION 1. Section 21-28-2.08 of the General Laws in Chapter 21-28 entitled "Uniform

1-2

Controlled Substances Act" is hereby amended to read as follows:

1-3

     21-28-2.08. Contents of schedules. -- Schedule I

1-4

      (a) Schedule I shall consist of the drugs and other substances, by whatever official name,

1-5

common or usual name, chemical name, or brand name designated, listed in this section.

1-6

      (b) Opiates. - Unless specifically excepted or unless listed in another schedule, any of

1-7

the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and

1-8

ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the

1-9

specific chemical designation:

1-10

      (1) Acetylmethadol

1-11

      (2) Allylprodine

1-12

      (3) Alphacetylmethadol

1-13

      (4) Alphameprodine

1-14

      (5) Alphamethadol

1-15

      (6) Benzethidine

1-16

      (7) Betacetylmethadol

1-17

      (8) Betameprodine

1-18

      (9) Betamethadol

2-19

      (10) Betaprodine

2-20

      (11) Clonitazene

2-21

      (12) Dextromoramide

2-22

      (13) Difenoxin

2-23

      (14) Diampromide

2-24

      (15) Diethylthiambutene

2-25

      (16) Dimenoxadol

2-26

      (17) Dimepheptanol

2-27

      (18) Dimethylthiambutene

2-28

      (19) Dioxaphetyl butyrate

2-29

      (20) Dipipanone

2-30

      (21) Ethylmethylthiambutene

2-31

      (22) Etonitazene

2-32

      (23) Extoxerdine

2-33

      (24) Furethidine

2-34

      (25) Hydroxypethidine

2-35

      (26) Ketobemidone

2-36

      (27) Levomoramide

2-37

      (28) Levophenacylmorphan

2-38

      (29) Morpheridine

2-39

      (30) Noracymethadol

2-40

      (31) Norlevorphanol

2-41

      (32) Normethadone

2-42

      (33) Norpipanone

2-43

      (34) Phenadoxone

2-44

      (35) Phenampromide

2-45

      (36) Phenomorphan

2-46

      (37) Phenoperidine

2-47

      (38) Piritramide

2-48

      (39) Proheptazine

2-49

      (40) Properidine

2-50

      (41) Propiram

2-51

      (42) Racemoramide

2-52

      (43) Trimeperidone

3-53

      (44) Tilidine

3-54

      (45) Alpha-methylfentanyl

3-55

      (46) Beta-hydroxy-3-methylfentanyl other names:

3-56

      N-[1-(2hydroxy-2-phenethyl)-3-methyl-4piperidingyl] Nphenylpropanamide

3-57

      (c) Opium Derivatives. - Unless specifically excepted or unless listed in another

3-58

schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever

3-59

the existence of the salts, isomers, and salts of isomers is possible within the specific chemical

3-60

designation:

3-61

      (1) Acetorphine

3-62

      (2) Acetyldihydrocodeine

3-63

      (3) Benzylmorphine

3-64

      (4) Codeine methylbromide

3-65

      (5) Codeine-N-Oxide

3-66

      (6) Cyprenorphine

3-67

      (7) Desomorphine

3-68

      (8) Dihydromorphine

3-69

      (9) Etorphine (Except hydrochloride salt)

3-70

      (10) Heroin

3-71

      (11) Hydromorphinol

3-72

      (12) Methyldesorphine

3-73

      (13) Methylihydromorphine

3-74

      (14) Morphine methylbromide

3-75

      (15) Morphine methylsulfonate

3-76

      (16) Morphine-N-Oxide

3-77

      (17) Myrophine

3-78

      (18) Nococodeine

3-79

      (19) Nicomorphine

3-80

      (20) Normorphine

3-81

      (21) Pholcodine

3-82

      (22) Thebacon

3-83

      (23) Drotebanol

3-84

      (d) Hallucinogenic Substances. - Unless specifically excepted or unless listed in another

3-85

schedule, any material, compound, mixture, or preparation, which contains any quantity of the

3-86

following hallucinogenic substances, or which contains any of its salts, isomers, and salts of

3-87

isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the

4-1

specific chemical designation (for purposes of this subsection only, the term "isomer" includes

4-2

the optical, position, and geometric isomers):

4-3

      (1) 3, 4-methylenedioxy amphetamine

4-4

      (2) 5-methoxy-3, 4-methylenedioxy amphetamine

4-5

      (3) 3, 4, 5-trimethoxy amphetamine

4-6

      (4) Bufotenine

4-7

      (5) Diethyltryptamine

4-8

      (6) Dimethyltryptamine

4-9

      (7) 4-methyl 2, 5-dimethoxyamphetamine

4-10

      (8) Ibogaine

4-11

      (9) Lysergic acid diethylamide

4-12

      (10) Marihuana

4-13

      (11) Mescaline

4-14

      (12) Peyote. Meaning all parts of the plant presently classified botanically as

4-15

Lophophora Williamsii Lemair whether growing or not; the seeds of the plant; any extract from

4-16

any part of the plant; and any compound, manufacture, salt, derivative, mixture, or preparation of

4-17

the plant, its seeds or extracts.

4-18

      (13) N-ethyl-3-piperidyl benzilate

4-19

      (14) N-methyl-3-piperidyl benzilate

4-20

      (15) Psilocybin

4-21

      (16) Psilocyn

4-22

      (17) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the

4-23

plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and

4-24

their isomers with similar chemical structure and pharmacological activity such as the following:

4-25

delta 1 cis or trans tetrahydrocannabinol, and their optical isomers. Delta 6 cis or trans

4-26

tetrahydrocannabinol and their optical isomers. Delta 3, 4 cis or trans tetrahydrocannabinol and

4-27

its optical isomer. (Since nomenclature of these substances is not internationally standardized,

4-28

compounds of these structures, regardless of numerical designation of atomic positions covered).

4-29

      (18) Thiophene analog of phencyclidine. 1-(1-(2 thienyl) cyclo-hexyl) pipiridine: 2-

4-30

Thienyl analog of phencyclidine: TPCP

4-31

      (19) 2,5 dimethoxyamphetamine

4-32

      (20) 4-bromo-2,5-dimethoxyamphetamine, 4-bromo-2,5-dimethoxy-alpha-

4-33

methylphenethyamine: 4-bromo-2,5-DMA

5-34

      (21) 4-methoxyamphetamine-4-methoxy-alpha-methylphenethylaimine:

5-35

paramethoxyamphetamine: PMA

5-36

      (22) Ethylamine analog of phencyclidine. N-ethyl-1- phenylcyclohexylamine, (1-

5-37

phenylcyclohexyl) ethylamine, N-(1-phenylcyclophexyl) ethylamine, cyclohexamine, PCE

5-38

      (23) Pyrrolidine analog of phencyclidine. 1-(1-phencyclohexyl)- pyrrolidine PCPy, PHP

5-39

      (24) Parahexyl; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-

5-40

6,6,9-trimethyl-6H-dibenz o (b,d) pyran: Synhexyl.

5-41

      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any

5-42

material, compound, mixture, or preparation which contains any quantity of the following

5-43

substances having a depressant effect on the central nervous system, including its salts, isomers,

5-44

and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible

5-45

within the specific chemical designation:

5-46

      (1) Mecloqualone.

5-47

      (2) Methaqualone.

5-48

      (3) 3-methyl fentanyl (n-( ethyl-1(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide.

5-49

      (4) 3,4-methyl-enedioxymethamphetamine (MDMA), its optical, positional and

5-50

geometric isomers, salts, and salts of isomers.

5-51

      (5) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts and

5-52

salts of isomers.

5-53

      (6) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP), its optical isomers, salts

5-54

and salts of isomers.

5-55

      (7) N-(1-(1-methyl-2-phenyl)ethyl-4-piperidyl)-N-phenyl-acetamide (acetyl-alpha-

5-56

methylfentanyl), its optical isomers, salts and salts of isomers.

5-57

      (8) N-(1-(1-methyl-2(2-thienyl)ethyl-4-piperidyl)-N-phenylpropanami de (alpha-

5-58

methylthiofentanyl), its optical isomers, salts and salts of isomers.

5-59

      (9) N-(1-benzyl-piperidyl)-N-phenylpropanamide (benzyl-fentanyl), its optical isomers,

5-60

salts and salts of isomers.

5-61

      (10) N-(1-(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenyl-propanamid e (beta-

5-62

hydroxyfentanyl), its optical isomers, salts and salts of isomers.

5-63

      (11) N-(3-methyl-1(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenylpro panamide (beta-

5-64

hydroxy-3-methylfentanyl), its optical and geometric isomers, salts and salts of isomers.

5-65

      (12) N-(3-methyl)-1-(2-(2-thienyl)ethyl-4-piperidyl)-N-phenylpro- panamide (3-

5-66

methylthiofentanyl), its optical and geometric isomers, salts and salts of isomers.

5-67

      (13) N-(1-2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide (thenylfentanyl), its

5-68

optical isomers, salts and salts of isomers.

6-1

      (14) N-(1-(2(2-thienyl)ethyl-4-piperidyl-N-phenylpropanamide (thiofentanyl), its optical

6-2

isomers, salts and salts of isomers.

6-3

      (15) N-[1-(2-phenylethyl)-4-piperidyl]N-(4-fluorophenyl)-propanamid e (para-

6-4

fluorofentanyl), its optical isomers, salts and salts of isomers.

6-5

      (16) Gamma hydroxybutyrate, HOOC-CH2-CH2-CH2OH, its optical, position, or

6-6

geometric isomers, salts and salts of isomers.

6-7

      (f) Stimulants. - Unless specifically excepted or unless listed in another schedule, any

6-8

material, compound, mixture, or preparation which contains any quantity of the following

6-9

substances having a stimulant effect on the central nervous system, including its salts, isomers,

6-10

and salts of isomers:

6-11

      (1) Fenethylline

6-12

      (2) N-ethylamphetamine

6-13

     (3) Methylenedioxymethcathinone (Methylone)

6-14

     (4) Methylenedioxpyrovalerone (MDPV)

6-15

     (5) Methylmethcathinone (Mephedrone)

6-16

     (6) Methoxymethcathinone

6-17

     (7) Fluoromethcathinone

6-18

      Schedule II

6-19

      (a) Schedule II shall consist of the drugs and other substances, by whatever official

6-20

name, common or usual name, chemical name, or brand name designated, listed in this section.

6-21

      (b) Substances, vegetable origin or chemical synthesis. - Unless specifically excepted or

6-22

unless listed in another schedule, any of the following substances whether produced directly or

6-23

indirectly by extraction from substances of vegetable origin, or independently by means of

6-24

chemical synthesis, or by a combination of extraction and chemical synthesis:

6-25

      (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or

6-26

opiate excluding naloxone and its salts, and excluding naltrexone and its salts, but including the

6-27

following:

6-28

      (i) Raw opium

6-29

      (ii) Opium extracts

6-30

      (iii) Opium fluid extracts

6-31

      (iv) Powdered opium

6-32

      (v) Granulated opium

6-33

      (vi) Tincture of opium

7-34

      (vii) Etorphine hydrochloride

7-35

      (viii) Codeine

7-36

      (ix) Ethylmorphine

7-37

      (x) Hydrocodone

7-38

      (xi) Hydromorphone

7-39

      (xii) Metopon

7-40

      (xiii) Morphine

7-41

      (xiv) Oxycodone

7-42

      (xv) Oxymorphone

7-43

      (xvi) Thebaine

7-44

      (2) Any salt, compound, derivative, or preparation which is chemically equivalent or

7-45

identical with any of the substances referred to in subdivision (1) of this subsection, except that

7-46

these substances shall not include the isoquinoline alkaloids of opium.

7-47

      (3) Opium poppy and poppy straw.

7-48

      (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and

7-49

any salt, compound, derivative, or preparation which is chemically equivalent or identical with

7-50

any of these substances, except that the substances shall not include decocainized coca leaves or

7-51

extraction of coca leaves, which extractions do not contain cocaine or ecgonine.

7-52

      (5) Concentrate of poppy straw (the crude extract of poppy straw in liquid, solid, or

7-53

powder form which contains the phenanthrine alkaloids of the opium poppy).

7-54

      (c) Opiates. - Unless specifically excepted or unless listed in another schedule any of the

7-55

following opiates, including its isomers, esters, ethers, salts; and salts of isomers, esters and,

7-56

ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the

7-57

specific chemical designation:

7-58

      (1) Alphaprodine

7-59

      (2) Anileridine

7-60

      (3) Bezitramide

7-61

      (4) Dihydrocodeine

7-62

      (5) Diphenoxylate

7-63

      (6) Fentanyl

7-64

      (7) Isomethadone

7-65

      (8) Levomethorphan

7-66

      (9) Levorphanol

7-67

      (10) Metazocine

8-68

      (11) Methadone

8-69

      (12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane

8-70

      (13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic

8-71

acid

8-72

      (14) Pethidine

8-73

      (15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

8-74

      (16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

8-75

      (17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

8-76

      (18) Phenaxocine

8-77

      (19) Piminodine

8-78

      (20) Racemethorphan

8-79

      (21) Racemorphan

8-80

      (22) Bulk Dextropropoxyphene (non-dosage forms)

8-81

      (23) Suffentanil

8-82

      (24) Alfentanil

8-83

      (25) Levoalphacetylmethadol

8-84

      (d) Stimulants. - Unless specifically excepted or unless listed in another schedule, any

8-85

material, compound, mixture, or preparation which contains any quantity of the following

8-86

substances having a stimulant effect on the central nervous system:

8-87

      (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers.

8-88

      (2) Methamphetamine, its salts and salts of its isomers.

8-89

      (3) Phenmetrazine and its salts.

8-90

      (4) Methylphenidate.

8-91

      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any

8-92

material, compound, mixture, or preparation which contains any quantity of the following

8-93

substances having a depressant effect on the central nervous system, including its salts, isomers,

8-94

and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible

8-95

within the specific chemical designation:

8-96

      (1) Amobarbital

8-97

      (2) Glutethimide

8-98

      (3) Methyprylon

8-99

      (4) Pentobarbital

8-100

      (5) Phencyclidine

8-101

      (6) Secobarbital

9-102

      (7) Phencyclidine immediate precursors:

9-103

      (i) 1-phencyclohexylamine

9-104

      (ii) 1-piperidinocyclohexane-carbonitrile (PCC)

9-105

      (8) Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some

9-106

other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzone ketone.

9-107

      Schedule III

9-108

      (a) Unless specifically excepted or unless listed in another schedule, any material,

9-109

compound, mixture, or preparation which contains any quantity of the following substances

9-110

having a depressant effect on the central nervous system:

9-111

      (1) Any substance which contains any quantity of a derivative of barbituric acid, or any

9-112

salt of a derivative of barbituric acid.

9-113

      (2) Chlorhexadol

9-114

      (3) Lysergic acid

9-115

      (4) Lysergic acid amide

9-116

      (5) Sulfondiethylmethane

9-117

      (6) Sulfonethylmethane

9-118

      (7) Sylfonmethane

9-119

      (8) Any compound, mixture, or preparation containing amobarbital, secobarbital,

9-120

pentobarbital, or any salt of them and one or more other active medicinal ingredients which are

9-121

not listed in any schedule.

9-122

      (9) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital or

9-123

any salt of any of these drugs and approved by the Food and Drug Administration for marketing

9-124

only as a suppository.

9-125

      (10) Ketamine, its salts, isomers and salts of isomers. (Some other names for ketamine:

9-126

(+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone).

9-127

      (b) Unless specifically excepted or unless listed in another schedule, any material,

9-128

compound, mixture, or preparation containing limited quantities of any of the following narcotic

9-129

drugs, or any salts of them:

9-130

      (1) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

9-131

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with an equal

9-132

or greater quantity of an isoquinoline alkaloid of opium.

9-133

      (2) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

9-134

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or

9-135

more active, nonnarcotic ingredients in recognized therapeutic amounts.

10-136

      (3) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

10-137

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

10-138

a fourfold or greater quantity of an isoquinoline alkaloid of opium.

10-139

      (4) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

10-140

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

10-141

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

10-142

      (5) Not more than one and eight tenths grams (1.8 gms.) of dihydrocodeine per one

10-143

hundred milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with

10-144

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

10-145

      (6) Not more than three hundred milligrams (300 mgs.) of ethylmorphine per one

10-146

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

10-147

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

10-148

      (7) Not more than five hundred milligrams (500 mgs.) of opium per one hundred

10-149

milliliters (100 mls.) or per one hundred grams (100 gms.) or not more than twenty-five

10-150

milligrams (25 mgs.) per dosage unit, with one or more active nonnarcotic ingredients in

10-151

recognized therapeutic amounts.

10-152

      (8) Not more than fifty milligrams (50 mgs.) of morphine per one hundred milliliters

10-153

(100 mls.) per one hundred grams (100 gms.) with one or more active, nonnarcotic ingredients in

10-154

recognized therapeutic amounts.

10-155

      (c) Stimulants. - Unless specifically excepted or listed in another schedule, any material,

10-156

compound, mixture, or preparation which contains any quantity of the following substances

10-157

having a stimulant effect on the central nervous system, including its salts, isomers, and salts of

10-158

the isomers whenever the existence of the salts of isomers is possible within the specific chemical

10-159

designation:

10-160

      (1) Benzphetamine

10-161

      (2) Chlorphentermine

10-162

      (3) Clortermine

10-163

      (4) Mazindol

10-164

      (5) Phendimetrazine

10-165

      (d) Steroids and hormones. - Anabolic steroids (AS) or human growth hormone (HGH),

10-166

excluding those compounds, mixtures, or preparations containing an anabolic steroid that because

10-167

of its concentration, preparation, mixture or delivery system, has no significant potential for

10-168

abuse, as published in 21 CFR 1308.34, including, but not limited to, the following:

10-169

      (1) Chlorionic gonadotropin

11-170

      (2) Clostebol

11-171

      (3) Dehydrochlormethyltestosterone

11-172

      (4) Ethylestrenol

11-173

      (5) Fluoxymesterone

11-174

      (6) Mesterolone

11-175

      (7) Metenolone

11-176

      (8) Methandienone

11-177

      (9) Methandrostenolone

11-178

      (10) Methyltestosterone

11-179

      (11) Nandrolone decanoate

11-180

      (12) Nandrolone phenpropionate

11-181

      (13) Norethandrolone

11-182

      (14) Oxandrolone

11-183

      (15) Oxymesterone

11-184

      (16) Oxymetholone

11-185

      (17) Stanozolol

11-186

      (18) Testosterone propionate

11-187

      (19) Testosterone-like related compounds

11-188

      (20) Human Growth Hormone (HGH)

11-189

      (e) Hallucinogenic substances.

11-190

      (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in

11-191

U.S. Food and Drug Administration approved drug product. (Some other names for dronabinol:

11-192

(6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9- trimethyl-3-pentyl-6H- dibenzo[b,d]yra n-1-ol,or(-)-

11-193

delta-9(trans)-tetrahydrocannabinol.)

11-194

      Schedule IV

11-195

      (1) Barbital.

11-196

      (2) Chloral betaine

11-197

      (3) Chloral hydrate

11-198

      (4) Ethchrovynol

11-199

      (5) Ethinamate

11-200

      (6) Methohexital

11-201

      (7) Meprobamate

11-202

      (8) Methylphenobarbital

11-203

      (9) Paraldehyde

12-204

      (10) Petrichloral

12-205

      (11) Phenobarbital

12-206

      (12) Fenfluramine

12-207

      (13) Diethylpropion

12-208

      (14) Phentermine

12-209

      (15) Pemoline (including organometallic complexes and chelates thereof).

12-210

      (16) Chlordiazepoxide

12-211

      (17) Clonazepam

12-212

      (18) Clorazepate

12-213

      (19) Diazepam

12-214

      (20) Flurazepam

12-215

      (21) Mebutamate

12-216

      (22) Oxazepam

12-217

      (23) Unless specifically excepted or unless listed in another schedule, any material,

12-218

compound, mixture, or preparation which contains any quantity of the following substances,

12-219

including its salts:

12-220

      Dextropropoxyphene(alpha-(+)-4-dimethylamino-1,2-diphenyl-3- methyl-2-

12-221

propronoxybutane).

12-222

      (24) Prazepam

12-223

      (25) Lorazepam

12-224

      (26) Not more than one milligram (1 mg.) of difenoxin and not less than twenty-five (25)

12-225

micrograms of atropine sulfate per dosage unit.

12-226

      (27) Pentazocine

12-227

      (28) Pipradrol

12-228

      (29) SPA (-)-1-dimethylamino-1, 2-diphenylethane

12-229

      (30) Temazepam

12-230

      (31) Halazepam

12-231

      (32) Alprazolam

12-232

      (33) Bromazepam

12-233

      (34) Camazepam

12-234

      (35) Clobazam

12-235

      (36) Clotiazepam

12-236

      (37) Cloxazolam

12-237

      (38) Delorazepam

13-238

      (39) Estazolam

13-239

      (40) Ethyl Ioflazepate

13-240

      (41) Fludizaepam

13-241

      (42) Flunitrazepam

13-242

      (43) Haloxazolam

13-243

      (44) Ketazolam

13-244

      (45) Loprazolam

13-245

      (46) Lormetazepam

13-246

      (47) Medazepam

13-247

      (48) Nimetazepam

13-248

      (49) Nitrazepam

13-249

      (50) Nordiazepam

13-250

      (51) Oxazolam

13-251

      (52) Pinazepam

13-252

      (53) Tetrazepam

13-253

      (54) Mazindol

13-254

      (55) Triazolam

13-255

      (56) Midazolam

13-256

      (57) Quazepam

13-257

      (58) Butorphanol

13-258

      (59) Sibutramine

13-259

      Schedule V

13-260

      (a) Any compound, mixture, or preparation containing any of the following limited

13-261

quantities of narcotic drugs, which shall include one or more non-narcotic active medicinal

13-262

ingredients in sufficient proportion to confer upon the compound, mixture, or preparation

13-263

valuable medicinal qualities other than those possessed by the narcotic drug alone:

13-264

      (1) Not more than two hundred milligrams (200 mgs.) of codeine per 100 milliliters (100

13-265

mls.) or per one hundred grams (100 gms.).

13-266

      (2) Not more than one hundred milligrams (100 mgs.) of dihydrocodeine per 100

13-267

milliliters (100 mls.) or per one hundred grams (100 gms.).

13-268

      (3) Not more than one hundred milligrams (100 mgs.) of ethylmorphine per 100

13-269

milliliters (100 mls.) or per one hundred grams (100 gms.).

13-270

      (4) Not more than two and five tenths milligrams (2.5 mgs.) of diphenixylate and not less

13-271

than twenty-five (25) micrograms of atropine sulfate per dosage unit.

14-272

      (5) Not more than one hundred milligrams (100 mgs.) of opium per one hundred

14-273

milliliters (100 mls.) or per one hundred grams (100 gms.).

14-274

      (b) Not more than five tenths milligrams (0.5 mgs.) of difenoxin and not less than

14-275

twenty-five (25) micrograms of atropine sulfate per dosage unit.

14-276

      (c) Buprenorphine

14-277

      (d) Unless specifically exempted or excluded or unless listed in another schedule, any

14-278

material, compound, mixture, or preparation which contains any quantity of the following

14-279

substances having a stimulant effect on the central nervous system, including its salts, isomers

14-280

and salts of isomers:

14-281

      (1) Propylhexedrine (except as benzedrex inhaler)

14-282

      (2) Pyrovalerone.

14-283

     SECTION 2. Title 21 of the General Laws entitled "Food And Drugs" is hereby amended

14-284

by adding thereto the following chapter:

14-285

     CHAPTER 28.8

14-286

THE GOOD SAMARITAN OVERDOSE PREVENTION ACT

14-287

     21-28.8-1. Short title. – This chapter shall be known and may be cited as “The Good 21

14-288

Samaritan Overdose Prevention Act”.

14-289

     21-28.8-2. Definition. – “Opioid antagonist” is a drug which is a competitive antagonist

14-290

23 that binds to the opioid receptors with higher affinity than agonists but does not activate the

14-291

receptors, effectively blocking the receptor, preventing the human body from making use of

14-292

opiates and endorphins.

14-293

     21-28.8-3. Authority to administer opioid antagonists – Release from liability. – (a)

14-294

A person may administer an opioid antagonist to another person if:

14-295

     (1) He or she, in good faith, believes the other person is experiencing a drug overdose;

14-296

and

14-297

     (2) He or she acts with reasonable care in administering the drug to the other person.

14-298

     (b) A person who administers an opioid antagonist to another person pursuant to this

14-299

section shall not be subject to civil liability or criminal prosecution as a result of the

14-300

administration of the drug.

14-301

     21-28.8-4. Emergency overdose care – Immunity from legal repercussions. – (a) Any

14-302

person who, in good faith, seeks medical assistance for someone experiencing a drug overdose or

14-303

other drug-related medical emergency shall not be charged or prosecuted for any crime related to

14-304

the possession or delivery of a controlled substance or drug paraphernalia, or the operation of a

14-305

drug-involved premises if the evidence for the charge was gained as a result of the seeking of

14-306

medical assistance.

15-1

     (b) Any person who experiences a drug overdose or other drug-related medical

15-2

emergency and is in need of medical assistance shall not be charged or prosecuted for any crime

15-3

related to the possession or delivery of a controlled substance or drug paraphernalia or the

15-4

operation of a drug-involved premises if the evidence for the charge was gained as a result of the

15-5

overdose and the need for medical assistance.

15-6

     (c) The act of providing first aid or other medical assistance to someone who is

15-7

experiencing a drug overdose or other drug-related medical emergency may be used as a

15-8

mitigating factor in a criminal prosecution pursuant to chapter 21-28 (Rhode Island controlled

15-9

substances act).

15-10

     SECTION 3. This act shall take effect upon passage.

=======

LC01487

=======

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N A C T

RELATING TO FOOD AND DRUGS -- DRUG ABUSE AND OVERDOSE PREVENTION

ACT

***

16-1

     This act would place Methylone, MDPV, Mephedrone and other compounds commonly

16-2

known and marketed as “bath salts” on schedule I of the uniform controlled substances act. This

16-3

would also create “The Good Samaritan Overdose Prevention Act” which would exempt from

16-4

liability any person who administers an opioid antagonist to another person to prevent a drug

16-5

overdose.

16-6

     This act would take effect upon passage.

=======

LC01487

=======